A request from 175 House Members follows an earlier Senate letter on safety protocols and oversight.
A group of 175 members of the U.S. House of Representatives, led by Representatives Chris Smith of New Jersey and Diana Harshbarger of Tennessee, sent a letter to the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) requesting information on how abortion medications are currently being distributed and monitored. The letter follows a similar request from 51 senators regarding the reinstatement of previous in-person medical requirements.
The legislators also want information about the FDA’s recent approval of a generic version of the medication and about ongoing policies that allow the drugs to be mailed to patients without an in-person consultation.
The House members raised concerns about the role of physician oversight, patient safety, and potential misuse of the drugs, while the administration conducts a broader assessment of safety standards.
As the Lord Leads, Pray with Us…
- For federal officials at HHS and the FDA as they evaluate safety protocols and determine regulations on medication distribution.
- For members of Congress involved in the inquiry as they seek information on how federal health policies are carried out.
Sources: Life News, Christian Post, PBS
